The Surface, Issue #2 is now available! Check out this month’s summaries of recent publications with high clinical relevance to Canadian dermatologists.

The Surface Issue #2, April edition, was sent to all PSOLVE+ members by email on Monday, March 29, and can be accessed online here. This edition covers:

  • Vaccine literacy amongst patients with psoriasis
  • Pregnancy outcomes from the PSOLAR registry
  • Bimekizumab phase 3 results in moderate-to-severe plaque psoriasis
  • Targeting the IL-23/IL-17 pathway in plaque psoriasis
  • Compassionately addressing teratogenic risk factors in the transgender population
  • Real-world safety profile of acitretin in psoriasis patients

To view all issues of The Surface, go to